THE DESCRIPTION OF MENSTRUAL BLEEDING PATTERNS - TOWARDS FEWER MEASURES

被引:28
作者
BELSEY, EM
CARLSON, N
机构
[1] World Health Organization, Geneva
关键词
D O I
10.1002/sim.4780100210
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The disturbance in menstrual bleeding induced by many methods of contraception is an important factor in their acceptability, and women participating in clinical trials of new methods are usually asked to keep a calendar record of the occurrence of bleeding. A recent WHO report recommends that, for analysis and presentation, each menstrual diary should be divided into successive periods, and the woman's bleeding pattern in each period summarized in ten indices. These indices are simple to calculate and easily understood by clinicians, but comparison of several groups is problematic because of the large number of summary statistics generated. Principal components analysis was therefore used to determine whether the indices could be reduced to a smaller number of measures. The analyses showed that three of the indices-the range and maximum value of bleeding/spotting episode lengths and the minimum bleeding-free interval-rarely measure their intended dimension of the bleeding pattern. Most of the essential information about a woman's bleeding pattern is contained in only four of the ten indices: the number of bleeding/spotting episodes, the mean lengths of episodes and intervals, and the range of bleeding-free interval lengths. Together, these indices describe the most important dimensions of a pattern: the amount, frequency and variability of the bleeding.
引用
收藏
页码:267 / 284
页数:18
相关论文
共 16 条
  • [1] A multicentred phase III comparative clinical trial of depot medroxyprogesterone acetate given three‐monthly at doses of 100 mg or 150 mg. 1: Contraceptive efficacy and side effects, Contraception, 34, pp. 223-235, (1986)
  • [2] Multinational comparative clinical trial of long‐acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot‐medroxyprogesterone acetate. Final report, Contraception, 28, pp. 1-20, (1983)
  • [3] A multicentred phase III comparative study of two hormonal contraceptive preparations given once‐a‐month by intramuscular injection. I: Contraceptive efficacy and side effects, Contraception, 37, pp. 1-20, (1988)
  • [4] Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I: Contraceptive efficacy and side‐effects, Contraception, 41, pp. 105-124, (1990)
  • [5] Belsey E.M., Machin D., d'Arcangues C., The analysis of vaginal bleeding patterns induced by fertility regulating methods, Contraception, 34, pp. 253-260, (1986)
  • [6] Belsey E.M., Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception, Contraception, 38, pp. 181-206, (1988)
  • [7] Belsey E.M., The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use, Contraception, 38, pp. 207-225, (1988)
  • [8] Belsey E.M., Peregoudov S., Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I: Regional variations, Contraception, 38, pp. 227-242, (1988)
  • [9] Snowden R., The statistical analysis of menstrual bleeding patterns, Journal of Biosocial Science, 9, pp. 107-120, (1977)
  • [10] Mullee M.A., Machin D., d'Arcangues C., A bibliography of the statistical analysis of vaginal bleeding patterns, Contraception, 38, pp. 259-285, (1988)